Skip to content
MedsAcross

Medicine

Linezolid 600 mg tablet

Linezolid · Oral
Available on requestPrescription onlyUS FDAGeneric name

Linezolid 600 mg tablet is a generic prescription medicine for oral use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25ºC (77ºF). Excursions permitted to 15 to 30 ºC (59 to 86…

Key facts

Active ingredient (INN)
Linezolid
Brand
Sold under the generic name
Strength
600 mg
Dosage form
Tablet
Route
Oral
Packs
20 tablets, 30 tablets, 100 tablets and 39 more
Manufacturers
Alembic PharmaceuticalsIndiaAscend LaboratoriesIndiaCamber PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaSportpharmBryant Ranch PrepackRising Pharma HoldingsA-S Medication SolutionsAmerican Health PackagingChartwell RX14 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25ºC (77ºF). Excursions permitted to 15 to 30 ºC (59 to 86 ºF).Protect from light. Keep bottles tightly closed to protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01XX08 Linezolid
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 December 2015
Identifiers
RxCUI 311347DailyMed set ID ab1b4ab5-7338-4b01-963b-43eeb4c9cf1c, 7368298b-d75c-4950-bbc1-00fc53f472ec, 7402aa01-50de-46c8-a341-d30da5b32b1c +14NDC 71335-2565, 85766-231, 67877-419 +14Application ANDA205517, ANDA078845, ANDA204239 +4

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 14 labelers. The register lists 42 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
20 tablet, film coated in 1 bottle46708-183-20Alembic PharmaceuticalsIndia22 December 2015
30 tablet, film coated in 1 bottle46708-183-30Alembic PharmaceuticalsIndia22 December 2015
100 tablet, film coated in 1 bottle46708-183-31Alembic PharmaceuticalsIndia22 December 2015
1000 tablet, film coated in 1 bottle46708-183-91Alembic PharmaceuticalsIndia22 December 2015
20 tablet, film coated in 1 bottle62332-183-20Alembic PharmaceuticalsIndia22 December 2015
30 tablet, film coated in 1 bottle62332-183-30Alembic PharmaceuticalsIndia22 December 2015
100 tablet, film coated in 1 bottle62332-183-31Alembic PharmaceuticalsIndia22 December 2015
1000 tablet, film coated in 1 bottle62332-183-91Alembic PharmaceuticalsIndia22 December 2015
100 tablet, film coated in 1 bottle67877-419-01Ascend LaboratoriesIndia21 December 2015
500 tablet, film coated in 1 bottle67877-419-05Ascend LaboratoriesIndia21 December 2015
1000 tablet, film coated in 1 bottle67877-419-10Ascend LaboratoriesIndia21 December 2015
20 tablet, film coated in 1 bottle67877-419-20Ascend LaboratoriesIndia21 December 2015
1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-419-33Ascend LaboratoriesIndia21 December 2015
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-419-38Ascend LaboratoriesIndia21 December 2015
3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-419-84Ascend LaboratoriesIndia21 December 2015
2 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack67877-419-85Ascend LaboratoriesIndia21 December 2015
100 tablet, film coated in 1 bottle31722-749-01Camber PharmaceuticalsIndia21 December 2015
20 tablet, film coated in 1 bottle31722-749-20Camber PharmaceuticalsIndia21 December 2015
30 tablet, film coated in 1 bottle31722-749-30Camber PharmaceuticalsIndia21 December 2015
150 tablet, film coated in 1 carton31722-749-31Camber PharmaceuticalsIndia21 December 2015
3 blister pack in 1 carton / 10 tablet, coated in 1 blister pack33342-352-06Macleods PharmaceuticalsIndia22 July 2026
100 tablet, coated in 1 bottle33342-352-11Macleods PharmaceuticalsIndia10 October 2024
5 blister pack in 1 carton / 10 tablet, coated in 1 blister pack33342-352-31Macleods PharmaceuticalsIndia10 October 2024
20 tablet, coated in 1 bottle33342-352-32Macleods PharmaceuticalsIndia10 October 2024
20 tablet in 1 bottle62135-442-20Chartwell RX21 February 2023
20 tablet in 1 bottle64980-561-02Rising Pharma Holdings20 November 2023
30 tablet in 1 bottle64980-561-03Rising Pharma Holdings20 November 2023
20 tablet, film coated in 1 bottle63629-8576-1Bryant Ranch Prepack16 December 2021
20 tablet, film coated in 1 bottle71335-2565-1Bryant Ranch Prepack28 January 2025
20 tablet in 1 bottle85766-075-20Sportpharm10 October 2025
30 tablet in 1 bottle85766-075-30Sportpharm10 October 2025
100 tablet, film coated in 1 bottle85766-231-01Sportpharm2 July 2026
20 tablet, film coated in 1 bottle85766-231-20Sportpharm2 July 2026
30 tablet, film coated in 1 bottle85766-231-30Sportpharm2 July 2026
60 tablet, film coated in 1 bottle85766-231-60Sportpharm2 July 2026
90 tablet, film coated in 1 bottle85766-231-90Sportpharm2 July 2026
20 tablet, film coated in 1 bottle50090-8044-0A-S Medication Solutions1 September 2026
30 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack60687-309-21American Health Packaging15 February 2018
30 tablet, film coated in 1 blister pack67046-1576-3Coupler4 September 2025
30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-6553-04Major Pharmaceuticals21 December 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 18 April 2000Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Linezolid 600 mg tablet.

Compare 1

Other strengths and forms of Linezolid

Clinical summary

Linezolid is an oxazolidinone antibacterial indicated in adults and children for the treatment of infections caused by susceptible Gram-positive bacteria, among other approved uses. It is available as tablets, injection and oral suspension for intravenous use. MedsAcross supplies Linezolid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Linezolid

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Linezolid 600 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.